Dominick Colangelo
President and CEO at Vericel Corporation
Sits on 2 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Vericel Corporation, 3 years.
Vericel Corporation
Director · President and CEO
Trevi Therapeutics Inc.
Director
Chief executive roles
Vericel Corporation
· President and CEO
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 14, 2024 | Vericel Corporation | Option exercise | +17,500 | $3.02 | $52,850 |
| Nov 14, 2024 | Vericel Corporation | Open-market sale | −17,500 | $53.93 | $943,775 |
| Nov 13, 2024 | Vericel Corporation | Option exercise | +17,500 | $3.02 | $52,850 |
| Nov 13, 2024 | Vericel Corporation | Open-market sale | −17,500 | $55.57 | $972,475 |
| Oct 17, 2024 | Vericel Corporation | Option exercise | +17,500 | $3.02 | $52,850 |
| Oct 17, 2024 | Vericel Corporation | Open-market sale | −17,500 | $40.34 | $705,950 |
| Oct 16, 2024 | Vericel Corporation | Option exercise | +17,500 | $3.02 | $52,850 |
| Oct 16, 2024 | Vericel Corporation | Open-market sale | −17,500 | $41.38 | $724,150 |
| Sep 12, 2024 | Vericel Corporation | Option exercise | +17,500 | $3.02 | $52,850 |
| Sep 12, 2024 | Vericel Corporation | Open-market sale | −17,500 | $43.90 | $768,250 |
| Sep 11, 2024 | Vericel Corporation | Option exercise | +17,500 | $3.02 | $52,850 |
| Sep 11, 2024 | Vericel Corporation | Open-market sale | −17,500 | $43.37 | $758,975 |
| Aug 15, 2024 | Vericel Corporation | Option exercise | +17,500 | $3.02 | $52,850 |
| Aug 15, 2024 | Vericel Corporation | Open-market sale | −17,500 | $46.24 | $809,200 |
| Aug 14, 2024 | Vericel Corporation | Option exercise | +17,500 | $3.02 | $52,850 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.